Mimedx Group Stock Buy Hold or Sell Recommendation
| MDXG Stock | USD 9.54 0.38 4.15% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding MiMedx Group is 'Strong Buy'. Macroaxis provides MiMedx buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MiMedx positions.
Check out MiMedx Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as MiMedx and provide practical buy, sell, or hold advice based on investors' constraints. MiMedx Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
MiMedx |
Execute MiMedx Buy or Sell Advice
The MiMedx recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on MiMedx Group. Macroaxis does not own or have any residual interests in MiMedx Group or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute MiMedx's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Buy
Market Performance | Good | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
MiMedx Trading Alerts and Improvement Suggestions
| MiMedx Group appears to be risky and price may revert if volatility continues | |
| MiMedx Group is unlikely to experience financial distress in the next 2 years | |
| About 68.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Acquisition by Maersk-moller Kimberly of 125581 shares of MiMedx subject to Rule 16b-3 |
MiMedx Returns Distribution Density
The distribution of MiMedx's historical returns is an attempt to chart the uncertainty of MiMedx's future price movements. The chart of the probability distribution of MiMedx daily returns describes the distribution of returns around its average expected value. We use MiMedx Group price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of MiMedx returns is essential to provide solid investment advice for MiMedx.
| Mean Return | 0.68 | Value At Risk | -2.97 | Potential Upside | 3.19 | Standard Deviation | 4.16 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of MiMedx historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
MiMedx Stock Institutional Investors
| Shares | Charles Schwab Investment Management Inc | 2024-09-30 | 1.4 M | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 1.2 M | Northern Trust Corp | 2024-09-30 | 1.1 M | Royal Bank Of Canada | 2024-09-30 | 1.1 M | Harbor Capital Advisors Inc | 2024-09-30 | 1 M | Royce & Associates, Lp | 2024-09-30 | 972.9 K | Federated Hermes Inc | 2024-09-30 | 906.8 K | Qube Research & Technologies | 2024-09-30 | 894.7 K | Richmond Brothers Inc | 2024-09-30 | 782.7 K | Essex Woodlands Health Ventures | 2024-09-30 | 28.2 M | Blackrock Inc | 2024-06-30 | 9.3 M |
MiMedx Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Other Non Cash Items | (53K) | (15.0M) | 2.1M | 4.6M | (4.8M) | (4.6M) | |
| Capital Expenditures | 10.0M | 2.2M | 3.5M | 2.7M | 2.0M | 3.6M | |
| Net Borrowings | 64.2M | (29.0M) | (38K) | (41K) | (47.2K) | (44.8K) | |
| Change To Netincome | 11.9M | 22.1M | 16.1M | 16.8M | 19.3M | 14.4M | |
| Investments | 2.7M | (4.6M) | (3.4M) | (2.7M) | (3.4M) | (3.6M) |
MiMedx Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to MiMedx or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that MiMedx's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a MiMedx stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.65 | |
β | Beta against Dow Jones | 0.27 | |
σ | Overall volatility | 4.26 | |
Ir | Information ratio | 0.14 |
MiMedx Volatility Alert
MiMedx Group has relatively low volatility with skewness of 4.22 and kurtosis of 20.78. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure MiMedx's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact MiMedx's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.MiMedx Fundamentals Vs Peers
Comparing MiMedx's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze MiMedx's direct or indirect competition across all of the common fundamentals between MiMedx and the related equities. This way, we can detect undervalued stocks with similar characteristics as MiMedx or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of MiMedx's fundamental indicators could also be used in its relative valuation, which is a method of valuing MiMedx by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare MiMedx to competition |
| Fundamentals | MiMedx | Peer Average |
| Return On Equity | 0.62 | -0.31 |
| Return On Asset | 0.18 | -0.14 |
| Profit Margin | 0.26 % | (1.27) % |
| Operating Margin | 0.14 % | (5.51) % |
| Current Valuation | 1.32 B | 16.62 B |
| Shares Outstanding | 146.95 M | 571.82 M |
| Shares Owned By Insiders | 2.45 % | 10.09 % |
| Shares Owned By Institutions | 68.13 % | 39.21 % |
| Number Of Shares Shorted | 3.42 M | 4.71 M |
| Price To Earning | 23.73 X | 28.72 X |
| Price To Book | 7.69 X | 9.51 X |
| Price To Sales | 4.06 X | 11.42 X |
| Revenue | 321.48 M | 9.43 B |
| Gross Profit | 219.53 M | 27.38 B |
| EBITDA | 40.52 M | 3.9 B |
| Net Income | 67.44 M | 570.98 M |
| Cash And Equivalents | 72.5 M | 2.7 B |
| Cash Per Share | 0.64 X | 5.01 X |
| Total Debt | 48.1 M | 5.32 B |
| Debt To Equity | 0.69 % | 48.70 % |
| Current Ratio | 3.53 X | 2.16 X |
| Book Value Per Share | 1.23 X | 1.93 K |
| Cash Flow From Operations | 26.77 M | 971.22 M |
| Short Ratio | 3.07 X | 4.00 X |
| Earnings Per Share | 0.59 X | 3.12 X |
| Price To Earnings To Growth | 2.97 X | 4.89 X |
| Target Price | 13.4 | |
| Number Of Employees | 895 | 18.84 K |
| Beta | 1.94 | -0.15 |
| Market Capitalization | 1.39 B | 19.03 B |
| Total Asset | 239.05 M | 29.47 B |
| Retained Earnings | (133.68 M) | 9.33 B |
| Working Capital | 118.25 M | 1.48 B |
Note: Acquisition by Maersk-moller Kimberly of 125581 shares of MiMedx subject to Rule 16b-3 [view details]
MiMedx Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as MiMedx . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About MiMedx Buy or Sell Advice
When is the right time to buy or sell MiMedx Group? Buying financial instruments such as MiMedx Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having MiMedx in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Casinos Thematic Idea Now
Casinos
Companies that are related to providing casino-type services across multiple geographical areas. The Casinos theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Casinos Theme or any other thematic opportunities.
| View All Next | Launch |
Check out MiMedx Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MiMedx. If investors know MiMedx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MiMedx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.1) | Earnings Share 0.59 | Revenue Per Share 2.447 | Quarterly Revenue Growth 0.029 | Return On Assets 0.1838 |
The market value of MiMedx Group is measured differently than its book value, which is the value of MiMedx that is recorded on the company's balance sheet. Investors also form their own opinion of MiMedx's value that differs from its market value or its book value, called intrinsic value, which is MiMedx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MiMedx's market value can be influenced by many factors that don't directly affect MiMedx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MiMedx's value and its price as these two are different measures arrived at by different means. Investors typically determine if MiMedx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MiMedx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.